Dell Donates More Than $10 Million to Support Global Children’s Cancer Care and Research
21 9월 2012 - 12:00AM
Business Wire
Dell is donating more than $10 million in its current fiscal
year to support children’s cancer research, and address the needs
of children and families worldwide undergoing treatment. Through
these global Powering the Possible grants, Dell is working with 10
nonprofit organizations, building on its multi-year commitment of
technology, funds and team-member volunteerism to support
innovative pediatric cancer programs.
Dell announced a partnership with the Translational Genomic
Research Institute (TGen) and the Neuroblastoma and Medulloblastoma
Translational Research Consortium (NMTRC) in 2011 to support the
world’s first FDA-approved personalized medicine clinical trial for
pediatric cancer. In that trial, a Dell high-performance computing
system reduced the time needed to analyze pediatric cancer tumor
cells from a week to less than a day. Dell’s donation this year
includes cloud-computing technology that will enable doctors to
collaborate virtually, identify personalized treatment and begin
administering it within days — a process that before took months.
And with these improvements, physicians are expanding the number of
children participating in the ground-breaking trial.
Dell is working with eight other nonprofits around the world to
address patients’ physical, mental and emotional needs as they
undergo treatment. These projects include:
- L’Institut Gustave Roussy (IGR), in
Paris. With Dell’s support, the hospital has launched a project,
“CREA FORM,” in its pediatrics department to keep children
connected to their peers and their studies during cancer treatment.
The initiative includes an online database of educational content,
a series of creative arts workshops, webcams that allow children
hospitalized in sterile rooms to stay in contact with other
children in the hospital, and a video project created by the
children themselves to introduce new patients to the hospital.
- Second Affiliated Hospital of Huaxi
(SCLF), in Chengdu, China. Though the most common forms of
childhood leukemia in China have very high cure rates, roughly 30
percent of children suffering from this disease gave up their
treatment at SCLF in 2010 due to lack of financial resources. With
Dell’s grant, SCLF will provide free treatment to children who have
successfully completed their first year of therapy, but who are
likely to suspend it for monetary reasons.
- Ronald McDonald House Charities (RMHC),
which works with Dell in 14 cities across the United States.
Because many families must travel for their children’s cancer
treatment, RMHC provides a “home away from home” at little to no
cost for families undergoing medical crisis. As part of their work
together, Dell team members will also volunteer at RMHC chapters,
providing much-needed help in addition to the financial
support.
In observation of National Childhood Cancer Awareness Month in
the United States, Dell this month also collaborated with
Causes.com to raise awareness of the deadly disease neuroblastoma —
the most common cancer in infants, accounting for roughly 15
percent of all childhood-cancer deaths. This fall, people visiting
Dell’s campaign at www.causes.com/dell can watch a video to learn
how technology is accelerating pediatric cancer treatment. Dell
will donate $1 for every viewer, up to $30,000, to the NMTRC, a
U.S. network of cancer trials conducted by researchers and
oncologists pioneering new therapies for children.
Quotes
“Every day in a child’s life is precious — that’s why technology
that can accelerate cancer treatment is so important. We’re honored
to bring our technology, team member support and funding to help
the fight against childhood cancer. In partnership with families,
nonprofits and the medical community, we know Dell can make a
difference.”Trisa Thompson, Vice President, Corporate
Responsibility, Dell
“It is critical for people to understand childhood cancers,
because doctors are finding more breakthroughs, and children are
surviving. There was a time if your child was diagnosed with
cancer, they’d say, ‘I’m sorry, there is nothing that we can do, so
go home and enjoy your time.’ That is not the case now. Thanks to
technology, doctors can look at Brooke’s DNA sequencing and study
her genomics and within 10 days say, ‘Here are her top five drugs
that we believe will turn her cancer off.’”Jessica Hester,
mother of Brooke Hester, 5-year-old neuroblastoma patient in
NMTRC’s trial
ABOUT DELL
Dell Inc. (NASDAQ: DELL) listens to customers and delivers
innovative technology and services that give them the power to do
more. Powering the Possible is Dell’s commitment to put technology
and expertise to work where it can do the most good for people and
the planet. Dell works with nonprofits to address pressing social
issues by donating a combination of Dell technologies and
solutions, funding, expertise and volunteer support. In 2011, Dell
gave more than $44 million, and Dell team members volunteered more
than 418,000 hours in their communities. Learn more at
www.dell.com/communities.
Dell is a trademark of Dell Inc. Dell disclaims any proprietary
interest in the marks and names of others.
Dell (NASDAQ:DELL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Dell (NASDAQ:DELL)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024